{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06220396",
            "orgStudyIdInfo": {
                "id": "23-007522"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study",
            "officialTitle": "CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study",
            "acronym": "CAMERA",
            "therapeuticArea": [
                "Other"
            ],
            "study": "cardiometabolic-function-and-reserve-capacity-in-healthy-adults-the-camera-study"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-28",
            "studyFirstSubmitQcDate": "2024-01-12",
            "studyFirstPostDateStruct": {
                "date": "2024-01-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Barry Borlaug",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate pulmonary capillary wedge pressure (PCWP) and other hemodynamic measurements at rest and during exercise in healthy volunteers across the age spectrum."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Healthy Volunteers",
                    "type": "EXPERIMENTAL",
                    "description": "Healthy volunteers with no history of Heart Failure (HF) will undergo a Right Heart Catheterization with Hemodynamics and Limited Echocardiogram, MRI, and DEXA scan.",
                    "interventionNames": [
                        "Procedure: Right Heart Catheterization with Hemodynamics and Limited Echocardiogram",
                        "Procedure: Magnetic Resonance Imaging (MRI)",
                        "Procedure: Dual X-ray absorptiometry (DEXA) scan"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Right Heart Catheterization with Hemodynamics and Limited Echocardiogram",
                    "description": "Right Heart Catheterization (RHC) with Hemodynamics and Limited Echocardiogram is an invasive procedure that involves insertion of a catheter through a blood vessel in the neck, groin, or arm to the right side of the heart. Hemodynamic measurements such as the blood pressure inside the veins, heart, and arteries as well as measurements of blood flow and how much oxygen is in the blood will be completed during the catheterization procedure. It is a way to see how well the heart is working during your procedure. During the RHC procedure a limited echocardiogram, using ultrasound waves, will be collected to evaluate the structure and function of the heart.\n\nAll measurements will be conducted at rest and during exercise using a supine cycle ergometer",
                    "armGroupLabels": [
                        "Healthy Volunteers"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Magnetic Resonance Imaging (MRI)",
                    "description": "MRI is a medical imaging technique that uses a magnetic field and computer-generated radio waves to create detailed images of the organs and tissues in your body. CMR Imaging will assess myocardial structure, function, and fat content.\n\nAn additional limited MRI sequence of the the abdomen and one sequence in the thigh will be used to evaluate for visceral adipose tissue (VAT) as a measurement of body composition.",
                    "armGroupLabels": [
                        "Healthy Volunteers"
                    ],
                    "otherNames": [
                        "CMR Imaging"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Dual X-ray absorptiometry (DEXA) scan",
                    "description": "A DEXA scan measures the amount of fat in the body using an x-ray that measures bone, calcium and fat.",
                    "armGroupLabels": [
                        "Healthy Volunteers"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pulmonary Capillary Wedge Pressure (PCWP) at rest",
                    "description": "Pulmonary capillary wedge pressure is a measure of cardiac filling pressure, measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter at rest.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Pulmonary Capillary Wedge Pressure (PCWP) during exercise",
                    "description": "Pulmonary capillary wedge pressure is a measure of cardiac filling pressure, measured using a high-fidelity micromanometer advanced through the lumen of a fluid-filled catheter during exercise.",
                    "timeFrame": "Baseline"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Trans-cardiac uptake of free fatty acids (FFA) at rest",
                    "description": "Trans-cardiac uptake of FFA will be measured using arterial and coronary sinus blood samples collected at rest during cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Trans-cardiac uptake of free fatty acids (FFA) during exercise",
                    "description": "Trans-cardiac uptake of FFA will be measured using arterial and coronary sinus blood samples collected during the exercise portion of the cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Trans-cardiac uptake of glucose at rest",
                    "description": "Trans-cardiac uptake of glucose will be measured using arterial and coronary sinus blood samples collected at rest during the cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Trans-cardiac uptake of glucose during exercise",
                    "description": "Trans-cardiac uptake of glucose will be measured using arterial and coronary sinus blood samples collected during the exercise portion of the cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Trans-cardiac uptake of ketone bodies at rest",
                    "description": "Trans-cardiac uptake of ketone bodies will be measured using arterial and coronary sinus blood samples collected at rest during the cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Trans-cardiac uptake of ketone bodies during exercise",
                    "description": "Trans-cardiac uptake of ketone bodies will be measured using arterial and coronary sinus blood samples collected during the exercise portion of the cardiac catheterization procedure.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Left ventricular (LV) global longitudinal strain",
                    "description": "LV global longitudinal strain will be assessed by echocardiography conducted during the cardiac catheterization procedure",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Left Atrial (LA) reservoir strain",
                    "description": "LA reservoir strain will be assessed by echocardiography conducted during the cardiac catheterization procedure",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Right Ventricular (RV) free wall strain",
                    "description": "RV free wall strain will be assessed by echocardiography conducted during the cardiac catheterization procedure",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Myocardial mass",
                    "description": "Myocardial mass will be measured by CMR imaging.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Myocardial volume",
                    "description": "Myocardial volume will be measured by CMR imaging.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Myocardial fat content",
                    "description": "Myocardial fat content will be measured by CMR imaging.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Body fat mass",
                    "description": "Body fat mass will be measured using dual X-ray absorptiometry (DEXA)",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Visceral fat content",
                    "description": "Visceral fat content will be measured using limited abdominal MRI",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Total blood volume",
                    "description": "Total blood volume will be assessed by using the radiolabeled iodinated albumin (131I, 5-25 \u03bcCu) indicator dilution technique (BVA-100 Blood Volume Analyzer, Daxor Corp, NY).",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Total plasma volume",
                    "description": "Total plasma volume will be assessed by using the radiolabeled iodinated albumin (131I, 5-25 \u03bcCu) indicator dilution technique (BVA-100 Blood Volume Analyzer, Daxor Corp, NY).",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Quality of Life (QOL) as assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ)",
                    "description": "KCCQ was a 23-item, self-administered questionnaire that measure the participant's perception of their health status, including their heart failure (HF) symptoms, impact on physical and social function and how their HF impacts the quality of life. KCCQ quantifies 7 domains: physical limitations (6 items), symptom stability (1 item), symptom frequency (4 items), symptom burden (3 items), self-efficacy (2 items), quality of life (3 items) and social limitations (4 items). Scores were generated for each domain and scaled from 0 to 100, with 0 (worst) and 100 (the best possible status), where the higher score reflected better health status.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Blood glucose level",
                    "description": "Blood glucose level will be measured using oral glucose tolerance testing",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Blood insulin level",
                    "description": "Blood insulin level will be measured using oral glucose tolerance testing",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Blood free fatty acids (FFA) level",
                    "description": "Blood FFA level will be measured using oral glucose tolerance testing",
                    "timeFrame": "Baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Apparently healthy volunteers are eligible to participate in this study if they are free of symptoms of exertional breathlessness or fatigue and any diagnosis of heart failure.\n* Patients will also be required to have left ventricular ejection fraction (EF) \u2265 50%.\n* Patients discovered to reduced EF or abnormal resting hemodynamics or other pathologic findings previously undiscovered will be considered screen failures and can be replaced by others to reach the goal enrollment.\n* Informed consent were obtained.\n* No history of heart failure.\n* Willing and able to undergo invasive hemodynamic exercise testing, MRI, and other study assessments.\n\nExclusion Criteria:\n\n* Clinically significant symptoms of exertional dyspnea or fatigue in daily life in the opinion of the investigators.\n* Any diagnosis of heart failure\n* Symptomatic coronary artery disease (e.g., patients with chronic angina)\n* Symptomatic valvular heart disease\n* Pulmonary hypertension\n* Cardiomyopathies\n* High output heart failure\n* Pericardial disease\n* Clinically significant chronic lung disease in the opinion of the investigators\n* Anemia (hemoglobin \\<12 gm/dL in women and \\<13 gm/dL in men)\n* Estimated glomerular filtration rate \u226430mL/min\n* Pregnant women\n* Any other disorders or problems that would interfere with the ability to participate safely in the study (e.g. psychiatric disorder or substance abuse)",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Dr. Borluag's Research Team",
                    "role": "CONTACT",
                    "phone": "507-255-2200"
                },
                {
                    "name": "Barry Borlaug, MD",
                    "role": "CONTACT",
                    "phone": "(507) 255-1051",
                    "email": "Borlaug.Barry@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Barry Borlaug, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dr. Borlaug's Research Team",
                            "role": "CONTACT",
                            "phone": "507-255-2200"
                        },
                        {
                            "name": "Barry Borlaug, MD",
                            "role": "CONTACT",
                            "phone": "(507) 255-1051",
                            "email": "Borlaug.Barry@mayo.edu"
                        },
                        {
                            "name": "Barry Borlaug, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}